[Federal Register Volume 70, Number 107 (Monday, June 6, 2005)]
[Notices]
[Pages 32773-32781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-11152]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Office of Global Health Cooperative Agreement for: Global
Capacity through International Non-Governmental Organization (NGO)
Partnership
Announcement Type: New.
Funding Opportunity Number: PA AA123.
Catalog of Federal Domestic Assistance Number: 93.067.
Key Dates: Application Deadline: July 6, 2005.
I. Funding Opportunity Description
Authority: Section 301 and 307 of the Public Health Service Act,
[42 U.S.C. Sections 241 and 242(l)], as amended.
Background: The Centers for Disease Control and Prevention (CDC)'s
global programs are an essential component of promoting health and
preventing disease in the United States and abroad, including ensuring
rapid detection and response to emerging health threats. CDC cannot
accomplish these efforts alone and therefore seeks to further its work
and interests through partnerships with other organizations. The Office
of Global Health seeks to collaborate with an international Non-
Governmental Organization (NGO) in a public-private partnership.
Working with a NGO with a strong international presence will leverage
existing resources to achieve health goals. CDC's knowledge and
abilities as a scientific organization can be effectively joined with
an international NGO that has demonstrated ability to effectively
implement public health interventions in many different countries. This
international NGO's experience in community-based interventions in a
variety of health topic areas will enable public health science to be
readily disseminated into the field. The intent of this announcement is
to enhance collaboration through building a public-private partnership,
and to create impact in health protection and promotion goals.
This partnership will focus in two areas: Global Disease Detection
(GDD) and a selection of the United Nations Millennium Development
Goals (MDG). The goal of the GDD initiative is to develop national and
international capacity to better detect and respond to infectious
disease outbreaks of potential worldwide importance, whether natural or
intentional. CDC is working to recognize infectious disease outbreaks
faster, improve the ability to control and prevent outbreaks, and to
detect emerging microbial threats. Through this cooperative agreement
CDC intends to work with an international NGO partner to pilot a
program to increase disease detection and surveillance in non-
traditional or resource poor settings. The goal of this pilot is to
build disease response and detection capacity in an international NGO
at the local level through communities, organizations, and the Ministry
of Health (MOH).
The Millennium Development Goals (MDG) are a framework of eight
goals, 18 targets, and 48 measures that were developed by experts from
the United Nations (UN), the International Monetary Fund (IMF), the
World Bank, and the Organization for Economic Cooperation and
Development (OECD). These goals were unanimously adopted by the member
states of the UN in September 2000 to focus on outcomes that promote
human development as the key to sustaining social and economic
progress. Several of these goals target areas of focus for the CDC
including maternal mortality, environmental health, and early childhood
health and development. Although the MDGs are visionary in nature,
projects supported through this cooperative agreement have the
potential for being antecedent steps toward attaining these goals
through increased service provision, learning capacity, and
demonstrated competence. The MDGs are eight goals that outline areas of
action, 18 targets that further define this involvement, and 48
indicators that provide measurable benchmarks for interventions. See
the following UN
[[Page 32774]]
Web site (http://www.un.org/millenniumgoals).
Purpose: The purpose of this announcement is to create an inter-
institutional relationship between the Centers for Disease Control and
Prevention (CDC) and an international Non-Governmental Organization
(NGO) that will serve as a bridge between CDC's public health science
and the selected grantee's community-based programming in several
functional areas in multiple countries. This cooperative agreement will
leverage resources and utilize different knowledge and perspective
between these two distinctive types of organizations. This announcement
will also provide a flexible mechanism for synergistic activities.
This cooperative agreement will leverage capacity in distinct areas
of: Global Disease Detection (GDD), Perinatal and Maternal Mortality
Reduction, Safe Water Systems (SWS)/Environmental Health Practices, and
Early Childhood Health and Development. This collaboration will promote
innovative solutions in a global partnership with extensive diversity,
resources, and experience. Initial funding is provided at this time for
Global Disease Detection and Maternal and Perinatal Mortality Reduction
activities. Other activities mentioned may be included, pending the
availability of supplemental funds in the future.
Initial collaboration and activities will be in support of the
following goals:
Global Disease Detection (GDD): This cooperative agreement is in
support of CDC's Global Disease Detection program and its goals of
increasing global capacity to prepare for, detect and verify, respond
to, and recover from naturally occurring and deliberate threats to
health. This will occur through objectives of strengthening sustainable
capacity in areas of epidemiology, laboratory, outbreak response,
disease monitoring, communications, and management.
Other projects in this announcement are in support of several
Millennium Development Goals (MDG) including:
Perinatal and Maternal Mortality Reduction:
Millennium Development Goal 5: Improve maternal health.
Target 6: Reduce by three quarters, between 1990 and 2015, the
maternal mortality ratio.
Indicator 16: Maternal mortality ratio (United Nations Children's
Fund--World Health Organization (UNICEF-WHO)).
Indicator 17: Proportion of births attended by skilled health
personnel (UNICEF-WHO).
Safe Water Systems (SWS)/Environmental Health Practice:
Target 10: Halve, by 2015, the proportion of people without
sustainable access to safe drinking water and sanitation.
Indicator 30: Proportion of population with sustainable access to
an improved water source, urban and rural (UNICEF-WHO).
Indicator 31: Proportion of population with access to improved
sanitation, urban and rural (UNICEF-WHO).
Early Childhood Health and Development:
Millennium Development Goal 4: Reduce Child Mortality.
Target 5: Reduce by two thirds, between 1990 and 2015, the under-
five mortality rate.
Indicator 13: Under-five mortality rate (UNICEF-WHO).
This announcement is only for non-research activities supported by
CDC/ATSDR. If research is proposed, the application will not be
reviewed. For the definition of research, please see the CDC Web site
at the following Internet address: http://www.cdc.gov/od/ads/opspoll1.htm.
Activities: Awardee activities for this program are as follows:
General: The CDC and the selected grantee will work together to
develop a long-term relationship, with logistical and multi-sectoral
outreach and education. This collaboration will establish a clear
understanding and protocols in areas of this undertaking. The grantee
must have the ability to work with multiple local country offices to
link and integrate projects in an international setting and liaison
with the CDC. Project findings in one country may be translated and
implemented in other settings; therefore the partnering organization
must have a worldwide network that includes a resident staff presence
in at least 60 countries worldwide.
The selected grantee in collaboration with the CDC will work to
determine appropriate sites for project implementation. The grantee
will explore the strategic interests of the country offices and their
on-the-ground staff, in order to identify the best possible sites for
collaboration. Once collaboration is established the grantee will move
from technical assistance to leadership and collaboration with sound
programming. The grantee will also devote the necessary resources and
time to monitor and evaluate the impact on the health system and the
health of the communities targeted. It is also expected that the
grantee will liaison with other CDC in-country programs in order to
avoid duplication and to identify areas for collaboration.
This cooperative agreement will function under the guidance of a
technical advisory group. As this agreement will cover a variety of
activities, the selected grantee must nominate a single point of
contact for all communication and information with CDC in order to
streamline the development and implementation of this collaboration.
Initial Funding is provided for the following activities:
Global Disease Detection (GDD): One focus of this announcement will
be to create emerging/reemerging disease detection capacity in a major
international Non-Governmental Organization (NGO) that has resident
staff in sixty or more countries.
In general, CDC expectations of the Global Disease Detection (GDD)
program are to: recognize infectious disease outbreaks faster, improve
the ability to control and prevent outbreaks, detect emerging microbial
threats, and to work with global partners. CDC will develop a
partnership with the chosen grantee to increase disease detection and
surveillance in non-traditional or resource poor settings. With CDC
assistance, the grantee will develop preparedness, recognition, and
response standards and protocols for emerging/re-emerging diseases.
Although final pilot project sites will be determined in collaboration
with CDC advisors, initial pilot project areas may include Vietnam and
India. Therefore, applicants must have a demonstrated capacity in
Vietnam and India in health and disease prevention.
Activities conducted under this cooperative agreement include but
are not limited to:
Assess current disease detection capacity and public
health infrastructure in pilot locations and plan resource appropriate
interventions.
Develop and improve local early warning systems.
Enhance collaboration with multinational organizations and
their partners.
Create evidence-based tools/practices for emerging/
reemerging diseases that can be realistically implemented in resource
poor communities.
Provide standardized GDD criteria for grantee response to
disease outbreaks.
Identify areas where coordinated detection and response
can occur.
Improve syndromic surveillance capabilities at a local
level.
[[Page 32775]]
Assess and utilize, if applicable, existing information
technology tools and evidence-based best practices to track infectious
disease outbreaks and their epidemiology.
Provide approaches that can be simultaneously coordinated
with ongoing surveillance initiatives--e.g. WHO's Global Outbreak Alert
Response Network (GOARN).
Utilize/apply geographic information system (GIS) based
approaches to outbreak detection.
Provide realistic ``threshold'' based approaches for
cluster detection and signal generation for outbreaks.
Develop plans to implement sustainable collaborations
between community animal-health workers or veterinary scientists and
public health agencies involved in human disease outbreak surveillance
program(s).
Outline roles of automated laboratory systems/Web-based
reporting in disease outbreak surveillance programs.
Identify ways to strengthen local and national laboratory
capacity.
Develop information on sources of infection, symptoms,
prevention techniques, and cross-species dangers.
Collect, analyze, and interpret data.
Identify appropriate communication media and messages.
Develop long-term plans to move beyond the initial
implementation phase and develop and disseminate interventions to other
countries.
Pilot a community-based intervention in the area of
emerging disease surveillance and detection within a grantee country
office. Funds will be provided for materials, training, and a workshop
in this area. It is envisaged that this pilot will occur in Vietnam or
India in response to concerns regarding avian influenza, or other
possible emerging/reemerging diseases.
Perinatal and Maternal Mortality Reduction: This cooperative
agreement will also focus on perinatal and maternal mortality
reduction. The focus will be on ensuring quality emergency obstetrics
care for women, creating strong referral systems in community-based
health services, improving community-based reproductive health
programs, and working with communities to address key barriers that
prevent women from receiving health services related to maternal
health. CDC's Division of Reproductive Health (DRH) and the Global AIDS
Program (GAP) will use this cooperative agreement to further
collaboration with grantees and to streamline their ability to
implement international projects. The CDC envisages perinatal and
maternal mortality reduction collaboration to initially begin in the
countries of: Afghanistan, Tajikistan, Ethiopia, and Tanzania, as well
as other countries in sub-Saharan Africa. Although final project sites
will be determined in collaboration between the selected grantee and
CDC advisors, applicants must have a demonstrated capacity in
Afghanistan, Tajikistan, Ethiopia, Tanzania, and sub-Saharan Africa in
this capacity.
Activities conducted under this cooperative agreement include but
are not limited to:
Develop, implement, and evaluate community-based
approaches, including but not limited to capacity building, empowerment
and other participatory approaches that promote maternal and child
health.
Implement a participatory model of community mobilization;
examine the capacity of the existing infrastructure to respond to
reproductive health needs; and address issues identified by communities
(e.g., assessing the need for maternity waiting homes for the at-risk
patient).
Implement maternal and infant health community
surveillance systems.
Survey and evaluate special populations, e.g.,
adolescents, refugees and HIV-infected population.
Analyze and define the parameters of reproductive health
programs.
Review quality of care provided in maternal child health
clinics (e.g., clinic management, patient flow analysis).
Expand and improve Prevention of Mother to Child HIV
Transmission (PMTCT) services.
Note: Other activities may be included in this cooperative
agreement in the future, pending the availability of funds. Although
funding may not be available at this time, the selected grantee
should have the capacity and intent to engage in these future
activities. Funding may be provided in a supplemental manner for the
following activities. Following federal protocols this would be
limited to a total for all supplemental activities of twenty-five
percent of the total base amount per annum.
Safe Water Systems (SWS)/Environmental Health Practice:
The safe water systems/environmental health practice component of
this announcement will work on several small discrete projects
determined in cooperation by the CDC and the selected grantee. Projects
will focus on working to develop the capacity to detect and monitor
emerging diseases as well as bacterial, foodborne, and waterborne
illnesses. Collaboration will also include the implementation of point-
of-use interventions including Safe Water System (SWS) approaches and
SWS trainings in both routine and emergency situations. The grantee may
expand these activities to include partnering with other organizations
in hand hygiene and SWS design.
The selected grantee will also conduct environmental health
practice projects. These projects may include providing the technical
assistance and expertise needed to develop sustainable environmental
health programs to ensure the identification and control of
environmental conditions contributing to disease. The Community
Environmental Health Assessment (CEHA) is one such process that builds
environmental health risk monitoring and develops local environmental
health capacity. Although final project sites will be determined in
collaboration between the selected grantee and CDC advisors, initial
environmental health practice project sites may focus on Latin America.
Therefore, applicants must have a demonstrated capacity in
environmental work in Latin America.
Activities conducted under this area of the cooperative agreement
include but are not limited to:
Strengthen collaboration between epidemiology, laboratory,
and environmental health services to monitor environmental and health
risks.
Identify and strengthen local and national laboratory
capacity.
Develop strategies to promote and strengthen community
participation in community-based environmental health and general
health assessments.
Develop local environmental health risk monitoring
systems.
Strengthen health surveillance activities at the primary
level in communities.
Collect, organize, analyze, and interpret health and
environmental data.
Early Childhood Health and Development: This cooperative agreement
will also seek to improve the health and development of orphaned and
vulnerable preschool-aged children through interventions provided at a
locally organized and managed daycare center that can be replicated in
other communities and sustained through community resources. In areas
of the world heavily impacted by the HIV/AIDS epidemic, young children
are often part of families in which one or both parents have died.
Preschool aged children are particularly vulnerable to the lack of
adequate physical, cognitive, and socioemotional nurturing. With a loss
of parents, and a breakdown of household structures, many communities
have resorted to forming daycare centers, run by widows or adolescent
orphans. If properly staffed
[[Page 32776]]
and resourced, these centers can provide much for attending young
children including nutrition, developmental stimulation, and emotional
support. Such nutrition, development, and emotional support can have a
large impact in the overall health of the child and may impact
childhood mortality rates. Integrated with the socio-emotional
development of the child are several health interventions including:
nutrition, health assessment, deworming (anti-helmentics), and other
basic health interventions. The goal of this project will be to
determine whether community daycare centers can provide interventions
and services that promote the health and development of young children
in resource-poor settings in a cost-effective and sustainable manner.
Although final project sites will be determined in collaboration
between the selected grantee and CDC advisors, an initial project site
may include Kenya. Therefore, applicants must have a demonstrated
capacity in Kenya, in education and child development.
Activities conducted under this cooperative agreement include but
are not limited to:
Assess and evaluate the developmental and health status of
pre-school aged children in HIV/AIDS impacted households in a pilot
community.
Evaluate whether developmental and health parameters of
orphaned and vulnerable children improve with participation in a
community daycare center.
Establish a minimum package of interventions in a
community daycare center, that includes health, cognitive, and
socioemotional development interventions.
Determine whether effective interventions for improving
early childhood development and health can be modified to be delivered
by minimally trained individuals and can utilize available local
materials.
Identify appropriate local partners.
Conduct evaluation and monitoring of projects, including a
cost-benefit analysis.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC Activities for this cooperative agreement include, but are not
limited to:
Determining project site locations and length of
implementation.
Assessing current disease detection capacity and public
health infrastructure in pilot locations and planning resource
appropriate interventions.
Creating evidence-based tools/practices for emerging/
reemerging diseases.
Developing plans to implement sustainable collaborations
in human disease outbreak surveillance program(s).
Identifying ways to strengthen local and national
laboratory capacity.
Piloting a Global Disease Detection community-based
intervention within a grantee country.
Collaborating on, developing, implementing, training for,
and integrating perinatal and maternal mortality surveillance systems
at the local level.
Training and implementation assistance on Safe Water
System (SWS) approaches.
Collaboration in conducting Community Environmental Health
Assessments (CEHA), and determining appropriate next steps.
Establishing a minimum package of early childhood health
and development interventions in a community daycare center.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: 2005.
Approximate Total Funding: $100,000.
$50,000 for Global Disease Detection and $50,000 for Perinatal and
Maternal Mortality Reduction.
Approximate Number of Awards: One.
Approximate Average Award: $100,000: $50,000 for Global Disease
Detection Activities and $50,000 for Perinatal and Maternal Mortality
Reduction Activities. (This amount is for the first budget period and
includes direct and indirect costs).
Floor of Award Range: None.
Ceiling of Award Range: $50,000 for Global Disease Detection and
$50,000 for Perinatal and Maternal Mortality Reduction Activities (For
the first 12 month budget period).
Anticipated Award Date: August 1, 2005.
Budget Period Length: 12 months.
Project Period Length: Five years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
III.1. Eligible applicants
Applications may be submitted by public and private
nonprofit and for profit organizations, and by governments and their
agencies, such as: Public nonprofit organizations; private nonprofit
organizations; for profit organizations; small, minority, women-owned
businesses; universities; colleges; research institutions; hospitals;
community-based organizations; and faith-based organizations that
possess the experience and ability to select and manage these projects.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding amount greater than the ceiling of the
award range, your application will be considered non-responsive, and
will not be entered into the review process. You will be notified that
your application did not meet the submission requirements.
Special Requirements: Eligible applicants must have a history of
experience and collaboration in the following areas: Global Disease
Detection (GDD), Perinatal and Maternal Mortality Reduction, Safe Water
Systems (SWS)/Environmental Health Practice, and Early Childhood Health
and Development.
Applicants must also follow the necessary procurement and grants
and reporting guidelines established by CDC. In addition, eligible
applicants will be a legal entity with approval to work, and memoranda
of understanding (MOUs) with Ministries of Health (MOH) in: Vietnam,
Afghanistan, Ethiopia, Tajikistan, Tanzania, Kenya, and India. Initial
areas of collaboration include these countries and therefore the
grantee must have ten years of experience and legal authority to work
in these countries. For environmental health practice projects, the
grantee must also demonstrate environmental capacity in Latin America
through evidence and history of related environmental projects.
CDC seeks to expand its global capacity through an NGO partnership
in an organization that has a strong international presence. Project
findings in one country may be translated and implemented in other
settings; therefore the partnering organization must have a worldwide
network that includes resident staff presence in at least 60 countries
worldwide.
[[Page 32777]]
Eligible grantees must also have demonstrated experience working at
a community-based level in a resource challenged environment including
experience in settings of extreme poverty and working with
disenfranchised individuals. Eligible entities must also possess
surveillance capacity with permanent staff on the ground, including
capacity at the local, district, and national level.
In addition for project specific portions, eligible entities must:
Global Disease Detection (GDD): In addition to previously discussed
areas, the selected partnering organization must demonstrate
proficiency in the following areas:
In-depth knowledge of the domestic situation in the
selected countries including but not limited to experience in:
Education, health, and development.
A broad international knowledge base with global
experience in areas such as: Health, HIV/AIDS, Emergency Humanitarian
Assistance, and Education.
Ability to work with local partners on areas of
Information, Education, and Communication (IEC) as well as Behavioural
Change Communication (BCC).
Ability to identify and implement projects within
established infrastructure, thus avoiding the creation of a vertical
program.
Capacity to carefully assess public health infrastructure
challenges such as the availability of personnel involved in field
epidemiology and public health laboratory functioning.
Perinatal and Maternal Mortality Reduction: In addition to
previously discussed areas, the selected partnering organization must
demonstrate proficiency in the following areas:
Experience operating from a community to health facility,
rather than a facility to community approach so that the local
community and its needs and concerns are incorporated from the
inception of the project.
Experience in both community organization and health
promotion in reducing maternal and perinatal mortality and promoting
women and newborn health.
Safe Water Systems (SWS)/Environmental Health Practice: In addition
to previously discussed areas, the selected partnering organization
must demonstrate proficiency in the following areas:
Capacity to detect and monitor emerging diseases as well
as bacterial, foodborne, and waterborne illnesses in settings of
extreme poverty with disenfranchised individuals.
Demonstrated experience with SWS in both routine and
emergency situations.
Familiarity with the SWS and training other organizations
and individuals in hand hygiene and SWS.
Familiarity in designing and implementing SWS.
Pre-existing agreements to operate in this area with
necessary local, and regional authorities.
Experience in strengthening local/regional/national
environmental health service infrastructure.
Experience in environmental risk monitoring, and community
involvement, including building local environmental health capacity.
Early Childhood Health and Development: In addition to previously
discussed areas, the selected partnering organization must demonstrate
proficiency in the following areas:
Capacity in educational and health programming including
experience in working in settings of extreme poverty and working with
disenfranchised individuals.
Experience working with community-level organizations to
address educational, health and developmental needs.
Capacity in addressing the impact of HIV/AIDS on education
programs.
Training local caregivers and other organizations in
education, health, and development.
Evaluation and monitoring capacity in education, health
and development.
If your application is incomplete or non-responsive to the special
requirements listed in this section, it will not be entered into the
review process. You will be notified that your application did not meet
submission requirements.
Late applications will be considered non-responsive. See
section ``IV.3. Submission Dates and Times'' for more information on
deadlines.
Note: Title 2 of the United States Code Section 1611
states that an organization described in Section 501(c)(4) of the
Internal Revenue Code that engages in lobbying activities is not
eligible to receive Federal funds constituting an award, grant, or
loan.
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity use application form PHS
5161-1.
Electronic Submission: CDC strongly encourages you to submit your
application electronically by utilizing the forms and instructions
posted for this announcement on http://www.Grants.gov, the official
Federal agency wide E-grant Web site. Only applicants who apply online
are permitted to forego paper copy submission of all application forms.
Paper Submission: Application forms and instructions are available
on the CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Application
Electronic Submission: You may submit your application
electronically at: http://www.grants.gov. Applications completed online
through Grants.gov are considered formally submitted when the applicant
organization's Authorizing Official electronically submits the
application to http://www.grants.gov. Electronic applications will be
considered as having met the deadline if the application has been
submitted electronically by the applicant organization's Authorizing
Official to Grants.gov on or before the deadline date and time.
It is strongly recommended that you submit your grant application
using Microsoft Office products (e.g., Microsoft Word, Microsoft Excel,
etc.). If you do not have access to Microsoft Office products, you may
submit a PDF file. Directions for creating PDF files can be found on
the Grants.gov Web site. Use of file formats other than Microsoft
Office or PDF may result in your file being unreadable by our staff.
CDC recommends that you submit your application to Grants.gov early
enough to resolve any unanticipated difficulties prior to the deadline.
You may also submit a back-up paper submission of your application. Any
such paper submission must be received in accordance with the
requirements for timely submission detailed in Section IV.3. of the
grant announcement. The paper submission must be clearly marked:
``BACK-UP FOR ELECTRONIC SUBMISSION.'' The paper submission must
conform with all requirements for non-electronic submissions. If both
electronic and back-up paper submissions are received by the deadline,
the electronic version will be considered the official submission.
[[Page 32778]]
Paper Submission: If you plan to submit your application by hard
copy, submit the original and two hard copies of your application by
mail or express delivery service. Refer to section IV.6. Other
Submission Requirements for submission address.
You must submit a project narrative with your application forms.
The narrative must be submitted in the following format:
Maximum number of pages: 30. If your narrative exceeds the
page limit, only the first pages which are within the page limit will
be reviewed.
Font size: 12 point unreduced.
Double spaced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Held together only by rubber bands or metal clips; not
bound in any other way.
Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed.
For Global Disease Detection and Perinatal and Maternal Mortality
Reduction please provide a Plan, Methods, Objectives, Timeline,
Participating Staff, Performance Measures, and a Budget Justification.
This budget justification should be for the first year only and include
direct as well as indirect costs. The budget justification will not be
counted in the stated page limit.
For Safe Water System (SWS)/Environmental Health Practice and Early
Childhood Health and Development Activities, please provide a brief
general description (one page per activity) that responds to the
activities outlined, in the case that funding is provided in the
future. Please also include evidence of appropriate eligible entity
criteria.
For all subject areas, please provide a description of your
demonstrated international capacity. Additionally, please describe your
minimum ten years of experience in Kenya, Tanzania, Tajikistan,
Afghanistan, Ethiopia, Vietnam, and India. Please mention your
appropriate evidence and capacity in environmental projects in Latin
America. Emphasis should be placed on your international network,
including a description on your resident staff in a minimum of sixty
countries worldwide.
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes: Memoranda of
Understanding (MOUs) with Ministries of Health, Curriculum Vitaes,
Resumes, Organizational Charts, Letters of Support, and additional
reporting requirement information.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-
5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm. If your application form does not have a
DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2.
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Times
Application Deadline Date: July 6, 2005.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you submit your application by the United States Postal
Service or commercial delivery service, you must ensure that the
carrier will be able to guarantee delivery by the closing date and
time. If CDC receives your submission after closing due to: (1) Carrier
error, when the carrier accepted the package with a guarantee for
delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the submission as having
been received by the deadline.
This announcement is the definitive guide on application content,
submission address, and deadline. It supersedes information provided in
the application instructions. If your submission does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that you did not meet the submission
requirements.
Electronic Submission: If you submit your application
electronically with Grants.gov, your application will be electronically
time/date stamped which will serve as receipt of submission. In turn,
you will receive an e-mail notice of receipt when CDC receives the
application. All electronic applications must be submitted by 4 p.m.
eastern time on the application due date.
Paper Submission: CDC will not notify you upon receipt of your
paper submission. If you have a question about the receipt of your
application, first contact your courier. If you still have a question,
contact the PGO-TIM staff at: 770-488-2700. Before calling, please wait
two to three days after the submission deadline. This will allow time
for submissions to be processed and logged.
IV.4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5. Funding restrictions
Restrictions, which must be taken into account while writing your
budget, are as follows:
Funds may not be used for research.
International Funding Restrictions:
Funds may be spent for reasonable program purposes,
including personnel, travel, supplies, and services. Equipment may be
purchased if deemed necessary to accomplish program objectives,
however, prior approval by CDC officials must be requested in writing.
The costs that are generally allowable in grants to
domestic organizations are allowable to foreign institutions and
international organizations, with the following exception: With the
exception of the American University, Beirut and the World Health
Organization, Indirect Costs will not be paid (either directly or
through sub-award) to organizations located outside the territorial
limits of the United States or to international organizations
regardless of their location.
The applicant may contract with other organizations under
this program; however the applicant must perform a substantial portion
of the activities (including program management and operations, and
delivery of prevention services for which funds are required.)
All requests for funds contained in the budget, shall be
stated in U.S. dollars. Once an award is made, CDC will not compensate
foreign grantees for currency exchange fluctuations through the
issuance of supplemental awards.
You must obtain annual audit of these CDC funds (program-
specific audit) by a U.S.-based audit firm with international branches
and current licensure/authority in-country, and in
[[Page 32779]]
accordance with International Accounting Standards or equivalent
standard(s) approved in writing by CDC.
A fiscal Recipient Capability Assessment may be required,
prior to or post award, in order to review the applicant's business
management and fiscal capabilities regarding the handling of U.S.
Federal funds.
HIV Programs (GAP) language that may also be applicable:
Funds received from this announcement will not be used for
the purchase of antiretroviral drugs for treatment of established HIV
infection (with the exception of nevirapine in Prevention of Mother-to-
Child Transmission (PMTCT) cases and with prior written approval),
occupational exposures, and non-occupational exposures and will not be
used for the purchase of machines and reagents to conduct the necessary
laboratory monitoring for patient care.
No funds appropriated under this act shall be used to
carry out any program of distributing sterile needles or syringes for
the hypodermic injection of any illegal drug.
Prostitution and Related Activities
The U.S. Government is opposed to prostitution and related
activities, which are inherently harmful and dehumanizing, and
contribute to the phenomenon of trafficking in persons.
Any entity that receives, directly or indirectly, U.S. Government
funds in connection with this document (``recipient'') cannot use such
U.S. Government funds to promote or advocate the legalization or
practice of prostitution or sex trafficking. Nothing in the preceding
sentence shall be construed to preclude the provision to individuals of
palliative care, treatment, or post-exposure pharmaceutical
prophylaxis, and necessary pharmaceuticals and commodities, including
test kits, condoms, and, when proven effective, microbicides. A
recipient that is otherwise eligible to receive funds in connection
with this document to prevent, treat, or monitor HIV/AIDS shall not be
required to endorse or utilize a multisectoral approach to combating
HIV/AIDS, or to endorse, utilize, or participate in a prevention method
or treatment program to which the recipient has a religious or moral
objection. Any information provided by recipients about the use of
condoms as part of projects or activities that are funded in connection
with this document shall be medically accurate and shall include the
public health benefits and failure rates of such use.
In addition, any recipient must have a policy explicitly opposing
prostitution and sex trafficking. The preceding sentence shall not
apply to any ``exempt organizations'' (defined as the Global Fund to
Fight AIDS, Tuberculosis and Malaria, the World Health Organization,
the International AIDS Vaccine Initiative or to any United Nations
agency), but does apply to any non-governmental, non-exempt
organization entity receiving U.S. Government funds from an exempt
organization in connection with this document.
The following definition applies for purposes of this clause:
Sex trafficking means the recruitment, harboring,
transportation, provision, or obtaining of a person for the purpose of
a commercial sex act. 22 U.S.C. 7102(9).
All recipients must insert provisions implementing the applicable
parts of this section, ``Prostitution and Related Activities,'' in all
subagreements under this award. These provisions must be express terms
and conditions of the subagreement, must acknowledge that compliance
with this section, ``Prostitution and Related Activities,'' is a
prerequisite to receipt and expenditure of U.S. Government funds in
connection with this document, and must acknowledge that any violation
of the provisions shall be grounds for unilateral termination of the
agreement prior to the end of its term. Recipients must agree that HHS
may, at any reasonable time, inspect the documents and materials
maintained or prepared by the recipient in the usual course of its
operations that relate to the organization's compliance with this
section, ``Prostitution and Related Activities.''
All prime recipients receiving U.S. Government funds (``prime
recipients'') in connection with this document must certify compliance
(pending OMB clearance) prior to actual receipt of such funds in a
written statement referencing this document (e.g., ``[Prime recipient's
name] certifies compliance with the section, `Prostitution and Related
Activities.' '') addressed to the agency's grants officer. Such
certifications by prime recipients are prerequisites to the payment of
any U.S. Government funds in connection with this document.
Recipients' compliance with this section, ``Prostitution and
Related Activities,'' is an express term and condition of receiving
U.S. Government funds in connection with this document, and any
violation of it shall be grounds for unilateral termination by HHS of
the agreement with HHS in connection with this document prior to the
end of its term. The recipient shall refund to HHS the entire amount
furnished in connection with this document in the event it is
determined by HHS that the recipient has not complied with this
section, ``Prostitution and Related Activities.''
Other
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement should be less than 12
months of age.
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm.
IV.6. Other Submission Requirements
Application Submission Address
Electronic Submission: CDC strongly encourages applicants to submit
electronically at: http://www.Grants.gov. You will be able to download
a copy of the application package from http://www.Grants.gov, complete
it offline, and then upload and submit the application via the
Grants.gov site. E-mail submissions will not be accepted. If you are
having technical difficulties in Grants.gov they can be reached by E-
mail at [email protected] or by phone at 1-800-518-4726 (1-800-518-
GRANTS). The Customer Support Center is open from 7 a.m. to 9 p.m.
eastern time, Monday through Friday.
Paper Submission: If you chose to submit a paper application,
submit the original and two hard copies of your application by mail or
express delivery service to:
You may submit your application electronically at: http://
www.grants.gov, OR submit the original and two hard copies of your
application by mail or express delivery service to: Technical
Information Management-PA AA123, CDC Procurement and Grants
Office, 2920 Brandywine Road, Atlanta, GA 30341.
V. Application Review Information
V.1. Criteria
Applicants are required to provide measures of effectiveness that
will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement. Measures of effectiveness must
relate to the performance goals stated in the ``Purpose'' section of
this announcement. Measures must be objective and quantitative, and
must measure the intended outcome. These measures of effectiveness must
be
[[Page 32780]]
submitted with the application and will be an element of evaluation.
Evaluation Criteria: The budget although not scored, will be
reviewed. Questions to be considered include: Is the itemized budget
for conducting the project, along with the justification, reasonable,
and consistent with the stated objectives and planned program
objectives?
Your application will be evaluated against the following criteria.
Global Disease Detection and Perinatal and Maternal Mortality
Reduction Plan (35 Points): Is the plan adequate to carry out the
proposed objectives?
Does the plan cover all necessary components?
How complete and comprehensive is the plan for the entire project
period?
Does this plan include quantitative process and outcome measures?
Does the plan maintain adequate surveillance, monitoring,
evaluation and data collection and analysis components?
Overall Methods (20 points): Are the proposed methods feasible? To
what extent will they accomplish the program goals?
Overall Reach and Capacity (20 points): Eligible applicants will be
a legal entity with approval to work and memoranda of understanding
(MOUs) with Ministries of Health (MOH) in: Vietnam, Afghanistan,
Ethiopia, Tajikistan, Tanzania, Kenya, and India. Initial areas of
collaboration include these countries and therefore the grantee must
have ten years of experience and legal authority to work in these
countries.
Does the applicant have demonstrated capacity in the listed
countries?
Does the applicant have MOUs and a minimum of ten years of
experience in the listed countries?
Does the eligible entity have experience of working in
environmental health practice in Latin America?
Does the applicant have programmatic capacity in all areas?
Does the applicant have demonstrated ability to implement public
health interventions internationally in resource-poor and non-
traditional settings?
Does the applicant have experience working with disenfranchised
populations?
Does the applicant have worldwide reach and partnership for the
dissemination of information, i.e., a resident staff presence in at
least sixty countries?
Does the applicant have sufficient community-based knowledge and
practice?
Does the applicant have the ability/capacity to work with local on
the ground staff to establish programs?
Overall Personnel (15 points): Do the staff members have the
appropriate experience?
Are the staff roles clearly defined?
As described, will the staff be sufficient to accomplish the
program goals?
Safe Water Systems (SWS)/Environmental Health Practice/Early
Childhood Health and Development Plan (10 Points): Is the plan adequate
to carry out the proposed objectives?
Does the plan cover all necessary components?
How complete and comprehensive is the plan for the entire project
period?
Does this plan include quantitative process and outcome measures?
Does the plan maintain adequate surveillance, monitoring,
evaluation and data collection and analysis components?
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by an objective
review panel. Incomplete applications and applications that are non-
responsive to the eligibility criteria will not advance through the
review process. Applicants will be notified that their application did
not meet submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above. The review will occur by CDC Employees from outside the
Office of Global Health. Applications will be funded in order by score
and rank determined by the review panel.
V.3. Anticipated Announcement and Award Dates
August 1, 2005.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Award (NoA) from the
CDC Procurement and Grants Office. The NoA shall be the only binding,
authorizing document between the recipient and CDC. The NoA will be
signed by an authorized Grants Management Officer, and mailed to the
recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
Successful applicants must comply with the administrative
requirements outlined in 45 CFR Part 74 as Appropriate. For more
information on the Code of Federal Regulations, see the National
Archives and Records Administration at the following Internet address:
http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
An additional Certifications form from the PHS5161-1 application
needs to be included in your Grants.gov electronic submission only.
Refer to http://www.cdc.gov/od/pgo/funding/PHS5161-1Certificates.pdf.
Once the form is filled out attach it to your Grants.gov submission as
Other Attachments Form.
The following additional requirements apply to this project:
AR-4 HIV/AIDS Confidentiality Provisions.
AR-5 HIV Program Review Panel Requirements.
AR-6 Patient Care.
AR-10 Smoke-Free Workplace Requirements.
AR-12 Lobbying Restrictions.
AR-13 Prohibition on Use of CDC Funds for Certain Gun
Control Activities.
AR-14 Accounting System Requirements.
AR-15 Proof of Non-Profit Status.
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two hard copies of the
following reports:
1. Interim progress report, due no less than 90 days before the end
of the budget period. The progress report will serve as your non-
competing continuation application, and must contain the following
elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Measures of Effectiveness.
f. Additional Requested Information.
2. Financial status report and annual progress report, no more than
90 days after the end of the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management or Contract
[[Page 32781]]
Specialist listed in the ``Agency Contacts'' section of this
announcement.
VII. Agency Contacts
We encourage inquiries concerning this announcement.
For general questions, contact: Technical Information Management
Section, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341. Telephone: 770-488-2700.
For program technical assistance, contact: Aaron Rak, MA, Centers
for Disease Control and Prevention, 1600 Clifton Road, MS D-58,
Atlanta, Georgia 30333. Telephone: (404) 498.4486. E-mail:
[email protected]. Patricia Riley, CNM MPH Project Officer, Office of Global
Health, Centers for Disease Control and Prevention, 1600 Clifton Road,
MS D-69, Atlanta, Georgia 30333. Telephone: (404) 639.1492. E-mail:
[email protected].
For financial, grants management, or budget assistance, contact:
Steward Nichols, Grants Management Specialist, CDC Procurement and
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341. Telephone: 770-
488-2788. E-mail: [email protected].
VIII. Other Information
This and other CDC funding opportunity announcements can be found
on the CDC Web site, Internet address: http://www.cdc.gov. Click on
``Funding'' then ``Grants and Cooperative Agreements.''
Dated: May 31, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 05-11152 Filed 6-3-05; 8:45 am]
BILLING CODE 4163-18-P